Page 1 | Search Results | Blood Advances | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis

Derek J. B. Kleinveld, Derek D. G. Simons, Charlotte Dekimpe, Shannen J. Deconinck, Pieter H. Sloos, M. Adrie W. Maas, Jesper Kers, Joshua Muia, Karim Brohi, Jan Voorberg, Karen Vanhoorelbeke, Markus W. Hollmann, Nicole P. Juffermans, on behalf of BloodNet

Blood Adv (2021) 5 (17): 3478–3491.

https://doi.org/10.1182/bloodadvances.2021004404

Published: 2021

Includes: Supplemental data

Journal Articles

Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura

Kadri Kangro, Elien Roose, Bérangère S. Joly, György Sinkovits, Tanja Falter, Charis von Auer, Heidi Rossmann, Marienn Reti, Jan Voorberg, Zoltán Prohászka, Bernhard Lämmle, Paul Coppo, Agnès Veyradier, Simon F. De Meyer, Andres Männik, Karen Vanhoorelbeke

Blood Adv (2021) 5 (17): 3427–3435.

https://doi.org/10.1182/bloodadvances.2020004172

Published: 2021

Includes: Supplemental data

Journal Articles

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

Blood Adv (2020) 4 (13): 3093–3101.

https://doi.org/10.1182/bloodadvances.2020001987

Published: 2020

Includes: Supplemental data

Journal Articles

Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function

An-Sofie Schelpe, Anastasis Petri, Elien Roose, Inge Pareyn, Hans Deckmyn, Simon F. De Meyer, James T. B. Crawley, Karen Vanhoorelbeke

Blood Adv (2020) 4 (6): 1072–1080.

https://doi.org/10.1182/bloodadvances.2019001375

Published: 2020

Includes: Supplemental data

Journal Articles

Verbij FC, Sorvillo N, Kaijen PHP, et al. The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages. Blood Adv. 2017;1(5):293-305.

Blood Adv (2020) 4 (3): 499.

https://doi.org/10.1182/bloodadvances.2020001542

Published: 2020

Journal Articles

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome

Alice Taylor, Chiara Vendramin, Deepak Singh, Martin M. Brown, Marie Scully

Blood Adv (2020) 4 (2): 398–407.

https://doi.org/10.1182/bloodadvances.2019000979

Published: 2020

Includes: Supplemental data

Journal Articles

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura

Jingrui Sui, Wenjing Cao, Konstantine Halkidis, Mohammad S. Abdelgawwad, Nicole K. Kocher, Bryan Guillory, Lance A. Williams, Radhika Gangaraju, Marisa B. Marques, X. Long Zheng

Blood Adv (2019) 3 (24): 4177–4186.

https://doi.org/10.1182/bloodadvances.2019000939

Published: 2019

Includes: Supplemental data

Journal Articles

Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome

Yoshihiro Fujimura, Bernhard Lämmle, Saori Tanabe, Kazuya Sakai, Toshiyuki Kimura, Koichi Kokame, Toshiyuki Miyata, Yukihiro Takahashi, Shigeki Taniguchi, Masanori Matsumoto

Blood Adv (2019) 3 (21): 3191–3195.

https://doi.org/10.1182/bloodadvances.2019000601

Published: 2019

Journal Articles

von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain

Changjie Zhang, Anju Kelkar, Sriram Neelamegham

Blood Adv (2019) 3 (7): 957–968.

https://doi.org/10.1182/bloodadvances.2018030122

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

James N. George

Blood Adv (2018) 2 (12): 1510–1516.

https://doi.org/10.1182/bloodadvances.2018018432

Published: 2018

Journal Articles

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu

Blood Adv (2017) 1 (23): 2075–2082.

https://doi.org/10.1182/bloodadvances.2017009308

Published: 2017

Journal Articles

Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13

Shobhit Gogia, Anju Kelkar, Changjie Zhang, Kannayakanahalli M. Dayananda, Sriram Neelamegham

Blood Adv (2017) 1 (23): 2063–2074.

https://doi.org/10.1182/bloodadvances.2017009027

Published: 2017

Includes: Multimedia, Supplemental data

Journal Articles

Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome

Yoko Yoshida, Masanori Matsumoto, Hideo Yagi, Ayami Isonishi, Kazuya Sakai, Masaki Hayakawa, Yuji Hori, Toshiyuki Sado, Hiroshi Kobayashi, Yoshihiro Fujimura

Blood Adv (2017) 1 (20): 1628–1631.

https://doi.org/10.1182/bloodadvances.2017006767

Published: 2017

Includes: Supplemental data

Journal Articles

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

John-Paul Westwood, Mari Thomas, Ferras Alwan, Vickie McDonald, Sylvia Benjamin, William A. Lester, Gillian C. Lowe, Tina Dutt, Quentin A. Hill, Marie Scully

Blood Adv (2017) 1 (15): 1159–1166.

https://doi.org/10.1182/bloodadvances.2017008268

Published: 2017

Journal Articles

Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels

Qianyi Ma, Paula M. Jacobi, Brian T. Emmer, Colin A. Kretz, Ayse Bilge Ozel, Beth McGee, Chava Kimchi-Sarfaty, David Ginsburg, Jun Z. Li, Karl C. Desch

Blood Adv (2017) 1 (15): 1037–1046.

https://doi.org/10.1182/bloodadvances.2017005629

Published: 2017

Includes: Supplemental data

Journal Articles

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Evaren E. Page, Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, James N. George

Blood Adv (2017) 1 (10): 590–600.

https://doi.org/10.1182/bloodadvances.2017005124

Published: 2017

Journal Articles

The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages

Fabian C. Verbij, Nicoletta Sorvillo, Paul H. P. Kaijen, Johana Hrdinova, Ivan Peyron, Rob Fijnheer, Anja ten Brinke, Alexander B. Meijer, Floris P. J. van Alphen, Timo K. van den Berg, Jonas J. H. Graversen, Soren K. Moestrup, Jan Voorberg

Blood Adv (2017) 1 (5): 293–305.

https://doi.org/10.1182/bloodadvances.2016001321

Published: 2017

Includes: Supplemental data

Journal Articles

Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura

Liang Zheng, Yingying Mao, Mohammad S. Abdelgawwad, Nicole K. Kocher, Mandy Li, Xiangrong Dai, Benjamin Li, X. Long Zheng

Blood Adv (2016) 1 (1): 75–83.

https://doi.org/10.1182/bloodadvances.2016000711

Published: 2016

Includes: Multimedia, Supplemental data

NARROW

Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis

Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function

Verbij FC, Sorvillo N, Kaijen PHP, et al. The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages. Blood Adv. 2017;1(5):293-305.

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura

Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome

von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13

Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages

Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only